Bennett Debbie L, Buckley Arianna, Lee Michelle V
Department of Breast Imaging, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, MO, USA.
Department of Breast Imaging, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, MO, USA.
Radiol Clin North Am. 2024 Jul;62(4):581-592. doi: 10.1016/j.rcl.2023.12.008. Epub 2024 Mar 7.
Fibrocystic changes are commonly seen in clinically symptomatic patients and during imaging workup of screening-detected findings. The term "fibrocystic changes" encompasses a broad spectrum of specific benign pathologic entities. Recognition of classically benign findings of fibrocystic changes, including cysts and layering calcifications, can prevent unnecessary follow-ups and biopsies. Imaging findings such as solid masses, nonlayering calcifications, and architectural distortion may require core needle biopsy for diagnosis. In these cases, understanding the varied appearances of fibrocystic change aids determination of radiologic-pathologic concordance. Management of fibrocystic change is typically conservative.
纤维囊性改变常见于有临床症状的患者以及筛查发现病变的影像学检查过程中。术语“纤维囊性改变”涵盖了一系列广泛的特定良性病理实体。认识到纤维囊性改变的典型良性表现，包括囊肿和分层钙化，可避免不必要的随访和活检。实性肿块、非分层钙化和结构扭曲等影像学表现可能需要进行粗针活检以明确诊断。在这些情况下，了解纤维囊性改变的多样表现有助于确定放射学与病理学的一致性。纤维囊性改变的管理通常是保守的。
